Brief: BridgeBio Raises $300 Mln Through Partial Capped Monetization Of Beyonttra European Royalty
30/06/2025 12:44
June 30 (Reuters) - BridgeBio Pharma Inc BBIO.O: BRIDGEBIO RAISES $300 MILLION THROUGH PARTIAL CAPPED MONETIZATION OF BEYONTTRA® EUROPEAN ROYALTY Source text: ID:nGNX60L9JJ Further company coverage: BBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BridgeBio Pharma
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
BridgeBio rises on FDA priority review for dwarfism drug
Brief: Bridgebio Announces FDA Acceptance And Priority Review Of NDA For Oral Infigratinib For Children With Achondroplasia
Brief: Bbp-418 Demonstrates Potential To Be Disease Modifying Therapy, Restoring Cardiac And Disease Markers To Unaffected Levels